Arthneeti
Latest: Insecticides India Ltd Q1 FY27 (Apr–Jun 2026) results →This page is Q4 FY26 (Jan–Mar 2026).All Q4 FY26 results →
I

Insecticides India Ltd

Q4 FY26Fertilizers & Agrochemicals

Insecticides India Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹610
Market cap₹1.8K Cr
P/E14.7
Updated23 Aug 2026
Read4 min read

The short version

Kaeros brand sales expected to at least double in the current fiscal year and potentially continue doubling over the next 3-4 years. The company expects both top-line (revenue) and bottom-line (profit) growth to be positive in FY27, with visible results from Q1 itself.

From Insecticides India Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Kaeros brand sales expected to at least double in the current fiscal year and potentially continue doubling over the next 3-4 years.
  • Kaeros brand to contribute 5%-8% to overall volumes; company targeting double-digit growth overall.
  • Top line (revenue) and bottom line (profit) expected to show positive growth starting Q1 FY27, dependent on monsoon season.
  • Export business projected to grow from 5% to around 10% of total sales over next 2-3 years, particularly from CDMO and technical products.
  • Continued expansion and launches of new patented and premium products aimed at increasing contribution to B2C revenues, targeting 60%-70% share in 3-4 years.

2 more points from Insecticides India Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Insecticides India Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Capex requirement going forward remains largely nominal or in the range of INR 25-30 crores, termed as maintenance capex after completing projects in FY27.
  • Manufacturing facilities at Sotanala and Dahej provide sufficient capacity headroom for future growth, ensuring scalability and operational flexibility.
  • At Dahej, a new building (L&T) has started manufacturing and is expected to breakeven and be profitable post-Diwali FY27.
  • Sotanala plant plans to start formulation around Diwali FY27; technical plant expected to start by March-April 2027.
  • Two buildings in Sotanala planned: first to start technical operations by early kharif 2027; second building construction to proceed based on market conditions.

2 more points from Insecticides India Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Insecticides India Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company mentions cautious optimism about demand for FY27, with improving pillar activity amid rising prices.
  • They highlight ongoing product launches and technology partnerships, including new products with Nissan and innovation through a joint venture with OAT.
  • Inventory levels were higher last fiscal due to investments in new products (~INR94 crores) and higher inventory holdings.
  • The company is actively working on improving cash collection and reducing days sales outstanding (DSO) to enhance liquidity.

2 more points from Insecticides India Ltd's call on order book

Create a free account to keep reading this call

Insecticides India Ltd — Quarterly revenue & net profit

Revenue Net profit
Sep 2024Q2 FY25
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26

Q4 FY26 figures are not in this chart yet. Latest shown: Dec 2025 (Q3 FY26). The Q4 FY26 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹385 Cr, net profit ₹10 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Insecticid.India's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

  • Rama Phosphates (Q4 FY26)

    Revenue grew by 20% year-on-year (Page 8). Key investor presentation takeaways from Rama Phosphates's Q4 FY26 investor presentation — and how it ranks against s

  • Khaitan Chemical (Q4 FY26)

    Q4-FY26 Operational Revenue: INR 1,930 million, up 20.1% YoY (from INR 1,607 million in Q4-FY25). Key investor presentation takeaways from Khaitan Chemical's Q4

  • Dhansa Labs (Q4 FY26)

    120-140 crores in additional annual revenue upon stabilization, with initial revenue of around Rs. Key concall takeaways from Dhansa Labs's Q4 FY26 earnings…

  • Advance Agrolife (Q4 FY26)

    Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…

Compare:vs Coromandel Intervs F A C Tvs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Insecticides India Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Insecticides India Ltd Q4 FY26 results?

Kaeros brand sales expected to at least double in the current fiscal year and potentially continue doubling over the next 3-4 years. The company expects both top-line (revenue) and bottom-line (profit) growth to be positive in FY27, with visible results from Q1 itself.

What is Insecticides India Ltd share price analysis?

Insecticides India Ltd currently shows a neutral. The stock trades at a P/E of 14.7 with a market cap of ₹1,837 Cr. Investors should review the full earnings analysis for detailed insights.

Is Insecticides India Ltd planning capital expenditure?

Capex requirement going forward remains largely nominal or in the range of INR 25-30 crores, termed as maintenance capex after completing projects in FY27.

Keep Insecticides India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.